INTRODUCTION
Sickle cell disorders and beta thalassaemia major are recessively inherited disorders affecting the structure or quantity of haemoglobin respectively. They are potentially life threatening, causing anaemia and a range of disabling morbidity. Sickle cell disorders are most common among people of African origin. Thalassaemias are more common among individuals originating from the Mediterranean, Indian subcontinent, and the Middle and Far East. However, haemoglobin gene variants may occur in any ethnic group, and this is now more common with greater ethnic diversity in relationships. There are an estimated 637 000 carriers of haemoglobin gene variants in England (1.2% of the whole population, and up to 25% of people in some ethnic groups). The most common haemoglobin gene variants are Hb S (sickle cell), Hb C, Hb beta thalassaemia, Hb E and Hb D Punjab.
Global population movement and mixing mean haemoglobin disorders are increasingly common in countries of Northern Europe and the US, where they were not previously endemic. Haemoglobin disorders and cystic fibrosis are now the most common recessively inherited disorders in the UK. People who carry a gene variant for one of these conditions are healthy, but can have an affected child if their partner is a carrier of the same condition.
Internationally, ad hoc screening for haemoglobin disorders is the most common model of diagnosis, but more systematic antenatal carrier screening occurs
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England is the only country in the world that currently has universal population screening for haemoglobin disorders through linked antenatal and newborn screening. Little is known about the acceptability of such screening.
Aim
To explore parents' experiences of, and attitudes towards, new universal genetic screening for haemoglobin disorders.
Design of study
Narrative interview study.
Setting
Primary and community care settings across England.
Method
Narrative interviews were undertaken with a maximum variation sample of 39 people who had experienced gene-carrier identification through antenatal and newborn screening for sickle cell, thalassaemia, and other haemoglobin variants within the previous 2 years.
Results
Most parents were unaware screening had occurred or had given it little consideration and so were surprised or shocked by results. However, they were glad to learn of their carrier status, reproductive genetic risk, or their newborn's carrier status. Participants emphasised that antenatal screening should happen as early as possible. Many would rather have known their carrier status before pregnancy or before entering a relationship. Although most were satisfied with the information they received, significant misunderstandings remained. There were culturally diverse attitudes towards prenatal diagnosis and termination. These procedures were acceptable to some parents with strong religious beliefs, including Christians and Muslims.
Conclusion
Parents support screening for haemoglobin disorders but need to be better informed and better prepared for results and what they mean. Sensitivity to patient diversity in attitudes and choices is also required. Universal screening for genetic reproductive risk will increasingly involve generalists, particularly in primary care, presenting opportunities for screening before or earlier in pregnancy, which is likely to be welcomed by patients.
within Southern European countries such as Greece, Italy, and Cyprus, and newborn screening for affected children occurs in the US and France. Iran has mandatory premarital screening. However, England is the only country in the world to have universal screening for sickle cell, beta thalassaemia, and other haemoglobin gene variants by linked antenatal and newborn screening programmes (Box 1).
This marks a shift from a traditional model of diagnosis of individuals affected by genetic disorders toward the screening of populations. The former has involved specialised genetic services. In contrast, population screening will require provision of information and explanation, particularly for people identified as gene carriers, by those in the 'frontline' of health care without specialist genetic expertise, such as midwives and physicians in primary, maternal, and child health care. It has been suggested that GPs may feel they lack relevant knowledge, skills, or confidence to contribute effectively to new genetic services, 1-3 but this will increasingly become a routine part of their work. Practitioners must be sufficiently informed to support pregnant women identified as carriers, and the parents of those babies identified as carriers. The aim of this study was to explore the experiences of parents offered new universal screening for haemoglobin disorders in order to inform clinical practice.
METHOD
The study was conducted as part of the DIPEx research project into personal experiences of health and illness, based at the University of Oxford. In line with established DIPEx methodology a maximum variation sample 4 was sought nationally, seeking variation across demographic factors as well as types of screening and diagnostic experiences. The aim of maximum variation sampling is to seek a broad range of experiences and identify differences as well as commonalities between groups and individuals. Participants were recruited through GPs and midwives, haematologists, genetic counsellors, specialist sickle cell and thalassaemia counsellors, and local and national support groups. Practitioners and support-group leaders were sent information about the project and copies of the information pack to hand out to potential participants. Those interested in taking part could either contact the researcher direct or give permission for their contact details to be passed to the researcher.
Thirty-nine people participated (including eight couples and one woman interviewed with her sisterin-law). Of these, 30 had experience of gene-carrier identification through antenatal screening and nine through newborn screening. Their characteristics, based on self-assigned ethnicity, are detailed in Table 1 .
In-depth narrative interviews were conducted either in the person's own home or elsewhere if preferred. Narrative interviewing empowers people to identify the issues that matter to them, in their own words, rather than being constrained by the language and priorities of professionals. Prompts were used after the initial narrative to elicit information about specific topics, such as attitudes to disability and termination, attitudes to risk and understanding of inheritance, if they had not already been covered. Interviews were videotaped or audiotaped and transcribed verbatim.
Nine responders were interviewed in languages
How this fits in
Little is known about the acceptability of universal population screening for haemoglobin disorders using linked antenatal and newborn screening programmes. This study suggests parents need to be better informed about such screening, and better prepared for the potential results. Some parents had significant misunderstandings about their carrier status and genetic reproductive risk, raising doubts about the effectiveness of information and communication offered to them. Parents show considerable diversity in their attitudes and choices in relation to screening, including prenatal diagnosis and termination of pregnancy. They support earlier screening, preconception.
Ǡ Antenatal screening
• As part of antenatal screening in England, all pregnant women are now screened for thalassaemias (using microcytosis, detected by routine full blood count).
• In high-prevalence (fetal prevalence of sickle cell of >1.5/10 000 pregnancies) areas every pregnant woman is also offered screening to see if she is a carrier of a sickle cell or other haemoglobin variant. In lower-prevalence areas this test is offered according to ancestry using a standard family origin questionnaire.
• There is a 1:4 risk of having an affected baby in each pregnancy if both parents are carriers.
• When a pregnant woman is found to be a carrier, the baby's father should be offered testing as soon as possible. The earlier in pregnancy that a couple 'at risk' is identified, the more time both individuals have to be referred for specialist counselling and to make choices about the pregnancy, and whether or not they want a prenatal diagnosis.
Ǡ Newborn screening
• Newborn screening for sickle cell disorders is now offered for all babies as part of the newborn bloodspot test in England. This is for the early identification of children affected with these disorders. However, an estimated 9000 babies per year who are healthy carriers will also be identified by the test.
• The interviews were coded and analysed thematically 5 using N6 computer-assisted qualitative data analysis software. The coding framework was developed using a modified grounded theory approach, 6 drawing on both emergent and anticipated themes from existing theory and research evidence, particularly on minority ethnic experiences of healthcare, patient decision-making, informed choice and consent, and lay understanding of risk. The attention to emergent themes again gives prominence to the perspectives of service recipients.
Data relevant to professional practice were identified and analysed. The coding framework and the thematic analysis were reviewed by a multidisciplinary advisory panel of experts on haemoglobinopathies. Summaries of the analysis and clips from the interviews can be seen at www.dipex.org/sicklecellandthalassaemia.
RESULTS

Being informed about screening
A minority of participants had actively requested carrier screening, either before or during pregnancy, but for most it occurred or was offered automatically during pregnancy. Many saw it as a routine blood test and some incorrectly believed it was mandatory. They had neither actively considered its implications nor expected results of any consequence. As one father explained:
'There was a leaflet but I just didn't take it seriously. I didn't understand.' (Appendix 1, Example 1)
Newborn screening for sickle cell disorders has been included in the heel prick test, long established in screening for phenylketonuria and congenital hypothyroidism. Again, many parents had not fully understood what the heel prick test was for. Immediately after birth, some parents found it difficult to absorb information about newborn screening. One mother explained she had other priorities following a difficult labour and some problems with the baby's health, and the screening result was wholly unanticipated: Responders would have liked to be more informed about screening, although it was unclear whether being asked for explicit consent was a particular issue. Even when people had not fully understood the test, virtually all were glad to have been made aware that they or their baby were carriers and recommended it to other parents. One exception was a mother who agreed to have prenatal diagnosis by chorionic villus sampling when she and her husband were identified as beta thalassaemia carriers. She has since regretted this and believed the procedure itself (which had to be repeated) may somehow have caused her child's beta thalassaemia major (Appendix 1, Example 3).
Timing of screening tests
While the opportunity to have antenatal screening was valued, many participants would rather have known their carrier status before becoming pregnant or choosing a partner. Some said they might not have started a relationship if they had known they were both carriers. This was true across a range of different faith groups and cultural backgrounds. As one mother said, 'If I had known right from the start that I was a carrier, I would have taken more care over my partner. I think I would have chosen a different partner.' (Appendix 2, Examples 1). Some participants from communities where arranged marriage is customary agreed that telling another family your son or daughter carries a genetic condition may be socially difficult (Appendix 2, Example 3).
However, most still thought it was better to be open about carrier status and that both potential partners should be screened before finalising an arranged marriage. Although they might not have had this opportunity themselves, they intended to make sure any of their own children who were carriers did not marry another carrier: Other participants said they would still have got married if they had known they were both carriers, but might have tried not to get pregnant or would have had prenatal diagnosis.
Within pregnancy, early screening and diagnosis was felt to be important. Some people felt they could only consider a termination early in pregnancy, whether for personal, emotional, or religious reasons. Some Islamic scholars teach that termination for lifethreatening conditions is permitted up to 120 days of pregnancy, at which point the soul enters the unborn baby ('ensoulment'). For some women this made the timing of screening and diagnosis vital, although not all Muslim parents were aware of or agreed with this teaching: 
Understanding carrier status and genetic risk
Most participants felt they were given good information to help them understand how genes are passed on, and particularly valued drawings or diagrams to demonstrate inheritance. However, many individuals worried at first that they or their baby were seriously ill when carrier status was identified (Appendix 3, Example 1). Some people appeared to have misunderstood the information provided or had added their own meanings or interpretations. Several people who knew they were carriers used expressions such as 'I've got thalassaemia -but it's not major'. One mother thought her daughter as a carrier had 'less blood from one side', and another thought one parent had 'good blood' and the other 'bad blood'. One woman believed being a thalassaemia carrier was something she caught 'because of dirt' (Appendix 3).
Achieving partner testing was influenced by people's assumptions about its relevance according to ethnic origin and the asymptomatic nature of being a carrier. Some participants were unaware that haemoglobin disorders could affect people of any ethnic origin, thus two women of African origin with white partners had not thought their partner needed to be screened. A white British man who learned as a child that he was a beta thalassaemia carrier had been advised that 'you shouldn't marry a Greek girl', so it was a shock when his English wife turned out to be a carrier.
Several women found it difficult to persuade the baby's father to be tested, either because he did not believe it was possible that he could be a carrier or because he was anxious about the test and needles, or both. Some men felt sure they were not carriers because they were fit and healthy, and told their partners they did not need to be screened (Appendix 4, Example 1). One white woman touched upon issues of non-paternity potentially being raised by screening when her baby was found to be a sickle cell carrier. She thought her white husband might have assumed she had been unfaithful: Participants varied in their understanding and perception of risk of having an affected pregnancy. Most understood that the risk of two carriers having an affected child was one in four, but others recalled the risk as less or greater than this. Even among those who clearly understood the risk of having an affected child was one in four, this meant different things. A mother with haemoglobin sickle cell disorder whose partner was a sickle cell carrier described her optimistic outlook, comparing her onein-four risk of having a baby with sickle cell anaemia to the risk of being knocked down by a car (which is, in fact, many times lower). A couple who were both sickle cell carriers declined prenatal diagnosis because they believed their strong Christian faith would protect the baby. In contrast an Italian couple, both thalassaemia carriers, felt preimplantation genetic diagnosis was the only option open to them as Catholics who would not consider termination. The man's sister had died of beta thalassaemia major and he regarded a one-in-four risk as unacceptably high, comparing it to placing the baby in one lane of a four-lane carriageway and waiting for a car to come along (Appendix 4, Example 3).
Communication of carrier results and advice about options
Most newborn results were sent by letter. Antenatal results were more commonly given by telephone, although some were posted. Participants felt there was no ideal way to learn that they or their baby carried a genetic disorder, but receiving a letter was distressing, especially if people were not really aware they had been screened -as one white woman said:
'I didn't know I was actually being tested for that … and then I had a letter saying that I had the beta thalassaemia trait … I was terrified, I didn't know what it was all about.' (Appendix 5, Example 1).
A phone call could still be a shock, but it was seen as preferable to receiving a letter. As one mother explained, 'If you've got that person on the line, you can actually ask questions straightaway' (Appendix 5, Example 2), and thereby find out more details and be reassured.
For people whose first language was not English, this posed an additional barrier to understanding their screening results. Some Urdu and Mirpuri speakers interviewed were pleased they had been able to
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Original Papers speak to a specialist counsellor in their own language. However, others sought information and counselling in their own language with less success.
Most people at risk of an affected pregnancy felt positive about how the options for prenatal diagnosis and continuing or ending the pregnancy were presented. Most felt the professionals involved, particularly specialist counsellors, had been nondirective. Some disliked the loneliness of decisionmaking in this situation and 'sort of wished that somebody had given us a guiding hand, because it was so hard to decide' (Appendix 5, Example 3), although a few felt counselling had been too directive (Appendix 5, Example 4).
Some people wanted to 'know the worst' about the conditions and all possible complications, while others felt staff could have given them more hope and a positive picture of them and their children managing successful lives with the conditions. Some responders wanted to know every detail about termination early on, while others were distressed that this might be a possibility. One father summed up the importance of health professionals exploring and being led by individual preference:
'I think I tried to prod them in a way, and say, you know, "If I have to go to termination, what is the steps?" They tried to be nice in a way, they tried not to go down that route … I think they were trying to be neutral, but in a way if the patients want to know, then they should give us the whole works rather than shield us.' (Appendix 5, Example 5)
Religious influences on individual decision making
In making decisions, participants were influenced by a range of personal, cultural, social, and religious values. Some people with strongly-held religious beliefs declined prenatal diagnosis, feeling that every human life is sacred and they should not question God's will for them. This group included both Christian and Muslim parents. Others were willing to accept screening, and to consider diagnostic tests in pregnancy so they could prepare themselves, even if they would not consider termination. Again, parents of both Christian and Muslim origin took this view.
Some participants described a sense of resignation to God's plan for them or positively embracing the challenge. One Pakistani Muslim mother said: The fact that a range of opinions can be seen across different faith groups means one cannot predict religious fatalism or acceptance on the basis of faith group. Further examples are shown in Appendix 6.
Strong faith was clearly a dominant force in some parents' decision making around screening and restricted what they perceived as the choices available to them. However, women of both Christian and Muslim faith were willing to consider termination. Some Muslim mothers wanted others to know that termination may be permissible within Islam under certain conditions, thereby providing a choice consistent with strong faith (see the section on 'Timing of tests'). For those Christian parents willing to consider termination, it was more a question of weighing up Christian objections to termination against other factors that were important to them, especially not wanting their baby to suffer.
People of other faiths or no strong religious convictions also described a process of balancing concerns about the baby, their moral values, and their own feelings as parents. This included a Buddhist couple who chose amniocentesis and felt they would definitely have terminated if the baby had beta thalassaemia major, and a Sikh woman whose husband was not a carrier, who thought she would have continued the pregnancy and declined prenatal diagnosis. This was more for personal than religious reasons, however:
'I wouldn't say it was religious. It was more just us, the way we think. Whereas our parents would be more religious, thinking, "Well you shouldn't terminate, full stop".'
The suggestion of generational difference is important; class and educational status may also have a bearing.
DISCUSSION
Summary of main findings
This study revealed the following main findings:
• Many people did not realise they were being screened or had not fully considered the implications, and were often shocked by the results.
• Most were glad to learn about their own or their child's carrier status.
• Communicating results by telephone or face-toface was preferred to receiving a letter.
• Many participants would prefer to be screened before conception or even before choosing a partner.
• Most felt it was important to be open about carrier status with potential partners.
• Partners need to appreciate they may still be carriers even though they are healthy, and regardless of ethnic origin.
• Some parents with strong religious faith may wish to consider prenatal diagnosis and perhaps termination of an affected pregnancy.
Comparison with existing literature
Green et al's review of the literature on the psychosocial aspects of genetic screening for pregnant women and newborns reports that most women in the general population hold positive attitudes towards antenatal screening for a range of conditions. 7 Studies reviewed by Green et al suggest that around 80% of women would prefer to have the screening option rather than just the diagnostic test option, and that 60-75% of women believe prenatal testing can empower them to make informed choices and that it is a maternal responsibility to ensure the health of the baby. A smaller percentage (approximately 10%) feel prenatal testing generates anxiety, medicalises pregnancy, and may stigmatise disability in society. However, there is substantial evidence that large gaps in women's knowledge exist and risk is not well understood. 7 There is less evidence on specific attitudes towards, and the acceptability of, haemoglobin disorder screening; 8 available evidence comes largely from the US. [9] [10] [11] [12] This and other work suggests that women may not be adequately informed about the purpose of screening tests and the nature of inherited risk, and that language problems may compound the already difficult task of gaining informed consent and explaining recessive inheritance. 13, 14 The current study's findings reinforce this evidence.
Although responders wanted to be more informed about screening, it was unclear whether being asked for their consent was a particular issue. This is consistent with a recent study of Pakistani women. 15 Obtaining informed consent for several antenatal and newborn screening tests may not be achievable in practice, where a blurring may occur between being told a test is being undertaken and gaining explicit consent. 15, 16 The current study's findings suggest personal communication of results was preferred to a letter. There is little previous evidence on acceptable and effective methods of communicating carrier status and more research is needed. 17, 18 Previous research has suggested that people are reluctant to disclose carrier status when arranging marriages. [19] [20] [21] This study's findings differ significantly; many of the responders wanted to know about carrier status before choosing a partner and recommended openness.
These findings emphasise the need to avoid assumptions about attitudes to prenatal diagnostic testing, termination, or having an affected child. [22] [23] [24] [25] [26] Regardless of attitudes to termination, prenatal testing can reduce anxiety if the fetus is unaffected, or allow parents to prepare for an affected pregnancy and best plan care for both their child and their own support. Raising awareness of Islamic teaching on termination might also help. 20, 24, 27 Previous work has found the main reason parents of Pakistani origin had comparatively lower use of prenatal diagnosis 28 was not Muslim objection to termination but, rather, inequality in service delivery. Screening was not undertaken or timely choices and options were not provided. 29 Like others, 22 this study found that a diagnostic test offered later in pregnancy may be unacceptable. The increasing use of chorionic villus sampling early in pregnancy is likely to make prenatal diagnosis more popular across all communities. 7, 30 Although more research into the perspectives of particular cultural or faith groups can raise awareness of concerns that are specific to those groups, it is important to bear in mind that this cannot be predictive of individual attitudes.
Strengths and limitations of the study
Narrative interviews offer participants a chance to explore in depth their attitudes and experiences. This sample included people from a wide range of ethnic, cultural, religious, and linguistic backgrounds, to provide a breadth of perspectives. Unlike earlier work prior to universal screening across England, 13, 14, 22 individuals of European origin were included. However, the numbers in each category were relatively small and further research with particular groups is desirable to give greater depth and nuance to the range of perspectives identified here.
A maximum variation sample in terms of screening experience was sought, and largely achieved, but did not find any participants who declined all screening. Nevertheless, accounts of partners refusing screening and parents declining prenatal diagnostic testing were included.
It was not possible to include experience of the early diagnosis of children affected by sickle cell disorders following universal newborn screening, given its recent implementation and within the confines of the study period. However, the sample does include those with children affected by haemoglobin disorders diagnosed before universal newborn screening was in practice.
Implications for clinical practice
This study highlights issues of growing importance for practitioners, with or without specialist genetics expertise, in primary, maternal, and child healthcare. The challenges are described below.
Timely provision of information. Specific written prescreening information is now available for England (www.sickleandthal.org.uk).
Providing similar information about newborn screening during pregnancy (www.ich.ucl.ac.uk/newborn), as well as at the time of the test, might help prepare parents for possible results. 16 Raising general awareness of these conditions and earlier screening among adults of reproductive age. Provision of information and carrier testing before pregnancy appears feasible in primary care 31, 32 and is supported by parents' perspectives here. This could ideally feature more routinely in future. It would also help to reduce 'information overload' and the need to explore such screening in pregnancy itself at a generally positive time for parents. Nevertheless, opportunities still exist for earlier screening when women first notify pregnancy, usually to a primary care practitioner. This is currently under investigation (www.controlled-trials.com/ISRCTN00677850).
Explaining the results. Primary and community staff may be the first port of call for people seeking further information after being told they are a carrier. Increasingly, with universal screening, people who have no prior knowledge or family history of haemoglobin disorders will discover they are carriers. The range of misunderstandings about carrier status among some responders raises doubts about the adequacy and effectiveness of information and communication offered to them. Practitioners must be able to explain the distinction between being a healthy carrier and having the condition, how recessive inheritance works, and why partner screening is recommended, regardless of ethnic origin.
Advice about choices. Generalist professionals should be familiar with the trajectory patients are likely to follow if identified as at risk. They should know where to refer patients promptly for partner testing or specialist counselling about options and prenatal diagnosis, according to local protocols. In doing so, it is important to be sensitive to individual diversity in attitudes and choices, and to avoid cultural or religious assumptions.
GPs perceive genetic service development as relevant to primary care 32 and the generalist approach, 33 but may feel ill-equipped to provide basic advice to those at genetic risk. 2 Specific resources are becoming available to help health professionals across disciplines with this new challenge (www.pegasus.nhs.uk/frontline/menu.htm and www.chime.ucl.ac.uk/APoGI).
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